FDA.reportPublic FDA data

acetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet

RxCUI
1037273
RxNorm name
acetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet
Display name
Acetaminophen/Phenyltoloxamine/Salicylamide (Oral Pill)
Full name
acetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet
Term type
SCD
Status
Active
Strength
300-20-200 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-17 23:43:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112010
Active start
112010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen300 MG / 1 EACHacetaminophenacetaminophen
phenyltoloxamine citrate20 MG / 1 EACHphenyltoloxaminephenyltoloxamine citrate
salicylamide200 MG / 1 EACHsalicylamidesalicylamide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
phenyltoloxamine33408
salicylamide9518

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRacetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet1NAMES
RxNorm Nameacetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet1NAMES
RxNorm SynonymAPAP 300 MG / Phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI10372731CODES
MMSL_CODECD126431CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00551018725rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCN02BASalicylic acid and derivativesATC1-4salicylamide
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientphenyltoloxamine
MEDRTD012457SalicylamidesCHEMhas_ingredientsalicylamide
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylamide
MEDRTD004342Drug HypersensitivityDISEASEci_withphenyltoloxamine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenyltoloxamine citrate
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005334FeverDISEASEmay_treatsalicylamide
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_treatsalicylamide
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatphenyltoloxamine citrate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatphenyltoloxamine
MEDRTD014581UrticariaDISEASEmay_treatphenyltoloxamine citrate
MEDRTD014581UrticariaDISEASEmay_treatphenyltoloxamine
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moasalicylamide
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaphenyltoloxamine citrate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaphenyltoloxamine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175439AnalgesiaPEhas_pephenyltoloxamine citrate
MEDRTN0000175439AnalgesiaPEhas_pephenyltoloxamine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008657Decreased Histamine ActivityPEhas_pephenyltoloxamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pephenyltoloxamine citrate
MEDRTN0000008832Decreased Platelet AggregationPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pesalicylamide
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH300 MG / 20 MG / 200 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESSNOMEDCT377391009
CODESVUID4007636
NAMESPrescribable Synonymacetaminophen 300 MG / phenyltoloxamine citrate 20 MG / salicylamide 200 MG Oral Tablet
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceUS Edition of SNOMED_CT